510(k) · Cleared

Cleared

Fetalgard Lite-Nibp, Model FGL-Nibp

K051903510(k) TraditionalCleared Dec 27, 2005167-day reviewClass II21 CFR 870.1130

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Analogic Corporation · DXN System, Measurement, Blood-Pressure, Non-Invasive

Cleared on Dec 27, 2005 as substantially equivalent to K002503 (Analogic Corp., 2000) and 1 other predicate after a 167-day review. Its family tree reaches back 2 generations to 1996.

Decided: Dec 27, 2005
Review: 167 days
Class: Class II
Product code: DXN
Recalls: None
Predicates: 2

Its longest line of descent runs back 2 generations to K962424 (1996). 3 ancestors in all. No later device cites it as a predicate yet.

By dateBy generation

Root · 2 generations backK962424 NPB-4000Analogic Corp. · 1996
1 generation backK030931 C3 Patient MonitorAnalogic Corp. · 2003
This deviceK051903 Fetalgard Lite-Nibp, Model FGL-NibpAnalogic Corporation · 2005

View FIG. 1 as a table

Line of descent and top descendants

Generation	Number	Device	Applicant	Decided	Recalls
−2	K962424	NPB-4000	Analogic Corp.	1996	—
−1	K030931	C3 Patient Monitor	Analogic Corp.	2003	—
0 (this device)	K051903	Fetalgard Lite-Nibp, Model FGL-Nibp	Analogic Corporation	2005	—

Other ancestors by year cleared

Year cleared	Devices	With a Class I recall
2000	1	0

FIG. 1 — Lineage of K051903, 1996–2005Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXN device

#1 K222125 Arm Blood Pressure Monitor, models AOJ-30A…score 18.5 · 8 generations · no Class I recall
#2 Held for the reportin the report
#3 Held for the reportin the report

Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

Type	Number	Device	Applicant	Decided	Recalls
*	K002503	Fetalgard Lite Summary page 2 …ve 5. Predicate Devices: The legally marketed devices to which equivalence is being claimed are: The FETALGARD Lite cleared under Premarket Notification K002503. This predicate device was chosen specifically for the fetal heart rate and uterine pressure indications. The C3 Pati…	Analogic Corp.	2000	—
*	K030931	C3 Patient Monitor Summary page 2 …edicate device was chosen specifically for the fetal heart rate and uterine pressure indications. The C3 Patient Monitor cleared under Premarket Notification K03093 1. The applicable part of this predicate device is the non-invasive blood pressure module and heart rate (derived from…	Analogic Corp.	2003	—

Also cleared against K002503: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

The line of descent spans 9 years and passes through 2 companies; a new generation was cleared every 6.4 years on median.
None of the 3 ancestors has a recall.
2 other devices also cite its predicate K002503.

How does its category compare?

All DXN devices

DXN System, Measurement, Blood-Pressure, Non-Invasive: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DXN

28in 2025

2007high 46 (2009) · low 17 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXN

142in 2025

2007high 235 (2018) · low 72 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXN

3in 2024

2007high 3 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXN

239in 2025

2007high 617 (2018) · low 8 (2008)2025

MAUDE reports naming product code DXN, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Decisions	Median 510(k) review, days	Recalls (Class I)	MAUDE reports
2007	27	118	0	21
2008	23	82	1	8
2009	46	73	3	17
2010	43	94	0	14
2011	34	72	1	10
2012	36	116	0	19
2013	34	150	1	72
2014	29	133	0	47
2015	30	97	0	62
2016	30	144	1	54
2017	33	184	0	90
2018	22	235	0	617
2019	33	156	1	96
2020	24	198	0	130
2021	23	190	0	162
2022	25	137	0	155
2023	35	182	0	162
2024	17	107	3	270
2025	28	142	0	239
2026	29	147	0	—

What is it indicated for?

The FETALGARD Lite-NIBP is a Perinatal Monitoring System for non-invasively measuring and showing graphically abdominal contractions, fetal heart rate, maternal non-invasive blood pressure, and maternal heart rate by means of display on a non-permanent graphical display and optionally on a printer. This data is to aid in assessing the well-being of the fetus and mother during the final trimester of pregnancy (non-stress test). This device is for use only by trained medical personnel located in hospitals, clinics, doctors' offices, and patient's home.

Indications for use as stated in the FDA summary.

https://510kreport.com/device/K051903 · printed Nov 6, 2026

Cite this page

510(k) Report. “K051903: Fetalgard Lite-Nibp, Model FGL-Nibp.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051903

Report an extraction error

Are you the manufacturer?

Record history

FDA decision record loaded May 2, 2026
Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
Lineage and recalls computed Nov 3, 2026
Page last updated Nov 3, 2026